Insider · CIK 0001763923
Suneel Gupta
Files at PTGX (Protagonist Therapeutics, Inc). First filing Nov 27, 2024, latest Nov 27, 2024.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
PTGX: Protagonist Therapeutics, Inc
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 50Moderate | Protagonist Therapeutics, Inc | $5.6M 122,628 shares | -34% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Nov 25, 2024 | PTGX Protagonist Therapeutics, Inc | MOption exercise Common Stock | +45,000 | $7.38 | $332k | 229,611 | Nov 27, 2024 |
| Nov 25, 2024 | PTGX Protagonist Therapeutics, Inc | MOption exercise Common Stock | +45,000 | $8.02 | $361k | 274,611 | Nov 27, 2024 |
| Nov 25, 2024 | PTGX Protagonist Therapeutics, Inc | MOption exercise Common Stock | +85,000 | $7.80 | $663k | 359,611 | Nov 27, 2024 |
| Nov 25, 2024 | PTGX Protagonist Therapeutics, Inc | SOpen-market sale Common Stock | -103,437 | $46.04 | $4.8M | 256,174 | Nov 27, 2024 |
| Nov 26, 2024 | PTGX Protagonist Therapeutics, Inc | MOption exercise Common Stock | +30,000 | $12.17 | $365k | 286,174 | Nov 27, 2024 |
| Nov 26, 2024 | PTGX Protagonist Therapeutics, Inc | SOpen-market sale Common Stock | -19,191 | $45.50 | $873k | 266,983 | Nov 27, 2024 |
| Nov 26, 2024 | PTGX Protagonist Therapeutics, Inc | MOption exercise Common Stock | +450 | $12.17 | $5,477 | 267,433 | Nov 27, 2024 |
| Nov 25, 2024 | PTGX Protagonist Therapeutics, Inc | MOption exercise Stock Option (right to buy)derivative | -45,000 | $0.00 | $0 | 0 | Nov 27, 2024 |
| Nov 25, 2024 | PTGX Protagonist Therapeutics, Inc | MOption exercise Stock Option (right to buy)derivative | -45,000 | $0.00 | $0 | 0 | Nov 27, 2024 |
| Nov 25, 2024 | PTGX Protagonist Therapeutics, Inc | MOption exercise Stock Option (right to buy)derivative | -85,000 | $0.00 | $0 | 0 | Nov 27, 2024 |
| Nov 26, 2024 | PTGX Protagonist Therapeutics, Inc | MOption exercise Stock Option (right to buy)derivative | -30,000 | $0.00 | $0 | 93,750 | Nov 27, 2024 |
| Nov 26, 2024 | PTGX Protagonist Therapeutics, Inc | MOption exercise Stock Option (right to buy)derivative | -450 | $0.00 | $0 | 93,300 | Nov 27, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.